cefuroxime has been researched along with Cataract in 21 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the impact of cefuroxime injection of intracameral prophylaxis antibiotic on after endophthalmitis operative wound following surgery of cataract, we conducted a meta-analysis." | 9.41 | Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis. ( Dong, H; Liu, Y; Wang, M, 2023) |
| "Our purpose was to compare postoperative infectious endophthalmitis rates before and after the introduction of antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery service." | 8.31 | The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center. ( de Sousa Casavechia, LN; Fernandes, AG; Fernandes, RAB; Meireles, AC; Schapira, E, 2023) |
| "To describe intracameral toxic effects of cefuroxime at a higher dose than recommended in cataract surgery." | 8.02 | Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery. ( Díez-Álvarez, L; Gómez-Mariscal, M; Jaumandreu, L; Muñoz-Negrete, FJ; Rebolleda, G; Salvá-Palomeque, T, 2021) |
| "The analysis aims to assess the cost-effectiveness of cefuroxime (Aprokam®) in the prophylaxis of postoperative endophthalmitis (POE) after cataract surgery compared with the absence of antibiotic prophylaxis from the National Health Fund perspective in Poland." | 7.96 | Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland. ( Dobrowolska, I; Golicki, D; Młyńczak, K; Niewada, M; Rękas, M, 2020) |
| "Patients who had cataract surgery with licensed cefuroxime prophylaxis between March 1, 2013, and July 31, 2015, and developed endophthalmitis were included." | 7.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "Acute toxic serous macular detachment after cataract surgery is very rare, and has been described previously with the use of high concentrations of intra-cameral cefuroxime." | 7.80 | Acute serous macular detachment and cystoid macular edema after uncomplicated phacoemulsification using standard dose subconjunctival cefuroxime. ( Althauser, S; Jain, S; Kontos, A; Mitry, D, 2014) |
| "To assess the impact of cefuroxime injection of intracameral prophylaxis antibiotic on after endophthalmitis operative wound following surgery of cataract, we conducted a meta-analysis." | 5.41 | Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis. ( Dong, H; Liu, Y; Wang, M, 2023) |
| "Our purpose was to compare postoperative infectious endophthalmitis rates before and after the introduction of antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery service." | 4.31 | The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center. ( de Sousa Casavechia, LN; Fernandes, AG; Fernandes, RAB; Meireles, AC; Schapira, E, 2023) |
| "To describe intracameral toxic effects of cefuroxime at a higher dose than recommended in cataract surgery." | 4.02 | Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery. ( Díez-Álvarez, L; Gómez-Mariscal, M; Jaumandreu, L; Muñoz-Negrete, FJ; Rebolleda, G; Salvá-Palomeque, T, 2021) |
| "The analysis aims to assess the cost-effectiveness of cefuroxime (Aprokam®) in the prophylaxis of postoperative endophthalmitis (POE) after cataract surgery compared with the absence of antibiotic prophylaxis from the National Health Fund perspective in Poland." | 3.96 | Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland. ( Dobrowolska, I; Golicki, D; Młyńczak, K; Niewada, M; Rękas, M, 2020) |
| "Patients who had cataract surgery with licensed cefuroxime prophylaxis between March 1, 2013, and July 31, 2015, and developed endophthalmitis were included." | 3.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "Acute toxic serous macular detachment after cataract surgery is very rare, and has been described previously with the use of high concentrations of intra-cameral cefuroxime." | 3.80 | Acute serous macular detachment and cystoid macular edema after uncomplicated phacoemulsification using standard dose subconjunctival cefuroxime. ( Althauser, S; Jain, S; Kontos, A; Mitry, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 10 (47.62) | 2.80 |
| Authors | Studies |
|---|---|
| Mahiat, C | 1 |
| Robaye, S | 1 |
| Levecq, L | 1 |
| Dumesnil, D | 1 |
| Sohy, C | 1 |
| Díez-Álvarez, L | 1 |
| Salvá-Palomeque, T | 1 |
| Jaumandreu, L | 1 |
| Gómez-Mariscal, M | 1 |
| Muñoz-Negrete, FJ | 1 |
| Rebolleda, G | 1 |
| Spackman, W | 1 |
| Raman, V | 1 |
| Melega, MV | 1 |
| Alves, M | 1 |
| Lira, RPC | 1 |
| Agarwal, A | 1 |
| Wang, M | 1 |
| Liu, Y | 1 |
| Dong, H | 1 |
| de Sousa Casavechia, LN | 1 |
| Meireles, AC | 1 |
| Schapira, E | 1 |
| Fernandes, RAB | 1 |
| Fernandes, AG | 1 |
| Dudeja, L | 1 |
| Agarwal, D | 1 |
| Kumar, A | 1 |
| Rękas, M | 1 |
| Młyńczak, K | 1 |
| Dobrowolska, I | 1 |
| Niewada, M | 1 |
| Golicki, D | 1 |
| Chen, KJ | 1 |
| Chong, YJ | 1 |
| Sun, MH | 1 |
| Chen, HC | 1 |
| Liu, L | 1 |
| Chen, YP | 1 |
| Wu, WC | 1 |
| Kang, EY | 1 |
| Lai, CC | 1 |
| Eggenschwiler, L | 1 |
| Savic Prince, S | 1 |
| Bubendorf, L | 1 |
| Walder, C | 1 |
| Goldblum, D | 1 |
| Grzybowski, A | 3 |
| Kanclerz, P | 1 |
| Kontos, A | 1 |
| Mitry, D | 1 |
| Althauser, S | 1 |
| Jain, S | 1 |
| Katz, G | 1 |
| Ehrlich, R | 1 |
| Tan, CS | 1 |
| Lim, LW | 1 |
| Chow, VS | 1 |
| Oh, LJ | 1 |
| Nguyen, CL | 1 |
| Wang, SS | 1 |
| Francis, IC | 1 |
| Mesnard, C | 1 |
| Beral, L | 1 |
| Hage, R | 1 |
| Merle, H | 1 |
| Farès, S | 1 |
| David, T | 1 |
| Barry, P | 1 |
1 review available for cefuroxime and Cataract
| Article | Year |
|---|---|
Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cefuroxime; Endophthalmitis; Humans; Postop | 2023 |
20 other studies available for cefuroxime and Cataract
| Article | Year |
|---|---|
Anaphylactic Shock Following Cataract Surgery: A Documented Intracameral Cefuroxime Allergy.
Topics: Anaphylaxis; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Drug Hypersensitivity | 2022 |
Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery.
Topics: Anti-Bacterial Agents; Cataract; Cefuroxime; Humans; Ophthalmology; Retrospective Studies; Toxic Opt | 2021 |
Acute exudative serous macular detachment with intraretinal oedema following uncomplicated phacoemulsification cataract surgery.
Topics: Cataract; Cefuroxime; Edema; Humans; Macular Edema; Male; Phacoemulsification; Retinal Detachment | 2022 |
Why do scientific advances take so long to be incorporated into clinical practice? The case of intracameral injection of antibiotics to prevent acute endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2022 |
Commentary: Preventing endophthalmitis after cataract surgery: An update.
Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, B | 2022 |
The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brazil; Cataract; Cataract Extracti | 2023 |
Commentary: Intracameral illumination for cataract surgery.
Topics: Cataract; Cataract Extraction; Cefuroxime; Humans; Lighting | 2019 |
Commentary: Role of antibiotics in cataract surgery.
Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; India; Mo | 2020 |
Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Cost-Benef | 2020 |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; C | 2021 |
Unexpected Intracameral Foreign Body during Routine Cataract Surgery.
Topics: Anterior Chamber; Cataract; Cataract Extraction; Cefuroxime; Foreign Bodies; Humans; Phacoemulsifica | 2017 |
The devil is in…the methodology: Issues to be clarified.
Topics: Cataract; Cefuroxime; Diabetes Mellitus; Humans | 2017 |
Acute serous macular detachment and cystoid macular edema after uncomplicated phacoemulsification using standard dose subconjunctival cefuroxime.
Topics: Anti-Bacterial Agents; Cataract; Cefuroxime; Female; Humans; Macular Edema; Middle Aged; Phacoemulsi | 2014 |
Re: "Incidence of post-cataract endophthalmitis with intracameral cefuroxime" letter to the editor.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Incidence of post-cataract endophthalmitis with intracameral cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |